RS Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-3,153
Closed -$260K 367
2015
Q3
$260K Hold
3,153
﹤0.01% 329
2015
Q2
$278K Hold
3,153
﹤0.01% 347
2015
Q1
$279K Sell
3,153
-195
-6% -$17.3K ﹤0.01% 349
2014
Q4
$278K Sell
3,348
-62,505
-95% -$5.18M ﹤0.01% 354
2014
Q3
$5.55M Sell
65,853
-19,794
-23% -$1.6M 0.05% 279
2014
Q2
$6.95M Buy
85,647
+224
+0.3% +$17.6K 0.06% 256
2014
Q1
$6.51M Sell
85,423
-3,912
-4% -$285K 0.04% 255
2013
Q4
$6.43M Buy
89,335
+26,928
+43% +$1.87M 0.04% 244
2013
Q3
$4.29M Buy
+62,407
New +$4.13M 0.03% 253

Other funds holding NVS

RS Investment Management's NVS Position: Q4 2015 in Review

RS Investment Management sold out of Novartis (NVS) in Q4 2015, closing a stake of 3,153 shares — an estimated $260K sold.

RS Investment Management first reported a position in NVS in Q3 2013 and held it in 9 quarters. The position peaked at $6.95M in Q2 2014. 927 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

  • RS Investment Management reported no remaining Novartis position as of Q4 2015 after selling out during the quarter.
  • RS Investment Management sold 3,153 Novartis shares in Q4 2015, an estimated $260K.
  • RS Investment Management first reported a position in Novartis in Q3 2013 and held it in 9 quarters.
  • RS Investment Management's Novartis position peaked at $6.95M in Q2 2014.
  • 927 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on RS Investment Management's 13F filing for Q4 2015, filed 11 Feb 2016.